---

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

---

 

 

FORM 8-K

 

 

CURRENT REPORT

 

 

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported):  November 17, 2003

 

 

---

 

 

Neose Technologies, Inc.

(Exact name of issuer as specified in charter)

 

 

DELAWARE		0-27718		13-3549286
(State or Other Jurisdiction of Incorporation or Organization)		(Commission file number)		(I.R.S. Employer Identification Number)

 

 

102 Witmer Road,

Horsham, Pennsylvania 19044

(Address of principal executive offices)

 

 

(215) 315-9000

(Registrant’s telephone number, including area code)

 

 

---

---

Item 5 — Other Events.

 

On November 17, 2003, the Company issued a press release announcing that it has entered into license agreements for improved therapeutic proteins with Novo Nordisk A/S. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

 

Item 7 — Financial Statements, Pro Forma Financial Information and Exhibits.

 

(a)

Financial Statements of Businesses Acquired: None

 

(b)

Pro Forma Financial Information: None

 

(c)

Exhibits: Reference is made to the Exhibit Index annexed hereto and made a part hereof.

---

Signatures

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

 

		NEOSE TECHNOLOGIES, INC.
Date:  November 17, 2003		By:		/S/    C. BOYD CLARKE
				C. Boyd Clarke President and Chief Executive Officer

---

Index to Exhibits

 

 

Exhibit No.		Description
Exhibit 99.1		Press Release dated November 17, 2003